title: Reply to G.B. Holt.
authors.affiliation: Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, MA alexi_wright@dfci.harvard.edu.
authors.forename: Alexi A
authors.initials: AA
authors.lastname: Wright
authors.affiliation: Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, MA.
authors.forename: Angel
authors.initials: A
authors.lastname: Cronin
authors.affiliation: The Ohio State University Comprehensive Cancer Center, Columbus, OH.
authors.forename: David M
authors.initials: DM
authors.lastname: O'Malley
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents